EUVIMEDEUVIMED entdecken
Open Access

Safety and Toxicity Evaluation of Stem Cell‐Based Vocal Fold Implant in Swine

Desiree Delavary iD, Larissa Nicolas, Dipti Sajed, Yazeed Alhiyari, Jennifer Long iD

The Laryngoscope · 2026

DOI: 10.1002/lary.70144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Laryngoscope, 2026. Verfasst von Desiree Delavary und 4 weiteren Autor:innen. Beteiligte Einrichtung: A.T. Still University School of Osteopathic Medicine, Mesa, Arizona, USA. Hauptthemen laut MEDLINE: Vocal Cords, Stem Cell Transplantation, Prostheses and Implants. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: RRD VA, NIDCD NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Introduction Prior to introduction in humans, new implant technology must be thoroughly assessed with preclinical animal trials. Cell‐based or cell‐derived therapies undergo FDA evaluation to be granted Investigational New Drug designation prior to human trials. While data required can vary across applications, standard safety and toxicity measures are valuable. We previously described a stem cell‐based vocal fold implant for reconstruction of the vibratory vocal fold. This study describes a proposed set of implant release criteria and safety and toxicity evaluation following this implantation in Yucatan minipigs.

Methods

Eight Yucatan minipigs underwent bilateral Cell‐based Outer Vocal Fold Replacement (COVR) containing multipotent human adipose stem cells. Perioperative corticosteroids and antibiotics were administered, but no chronic immunosuppressive medications were given. As a control, three additional animals had vocal fold resection without COVR implant and underwent an identical medication regimen. The animals were monitored for 6 months, with interval blood draws to measure basic chemistry, hematologic, and liver function tests. Any adverse events were recorded.

Results

Several animals demonstrated minor serologic findings outside of the defined normal range, but none demonstrated severe abnormalities. Adverse events included skin wound dehiscence in two animals and gastrointestinal symptoms accompanied by a temporary behavior change. All adverse events resolved following empiric treatment. Histologic examination demonstrated varying degrees of local immune response.

Conclusions

Hematologic and metabolic safety monitoring has thus far demonstrated no serious toxicity after xenograft vocal fold implantation in immunocompetent swine. Adverse events related to surgical complications are reported. Level of Evidence N/A.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vocal CordsStem Cell TransplantationProstheses and ImplantsAnimalsSwineSwine, MiniatureFemale

Autor:innen und Institutionen

  • A.T. Still University School of Osteopathic Medicine, Mesa, Arizona, USA.
  • Department of Head & Neck Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Department of Laboratory Medicine and Pathology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Greater Los Angeles VA Medical Center, Los Angeles, California, USA.

ORCID-Profile: Desiree Delavary, Jennifer Long

Förderung

  • RRD VA
  • NIDCD NIH HHS
  • National Institutes of Health

Zitieren

APA

Delavary, D., Nicolas, L., Sajed, D., Alhiyari, Y., & Long, J. (2026). Safety and Toxicity Evaluation of Stem Cell‐Based Vocal Fold Implant in Swine. The Laryngoscope. https://doi.org/10.1002/lary.70144

Vancouver

Delavary D, Nicolas L, Sajed D, Alhiyari Y, Long J. Safety and Toxicity Evaluation of Stem Cell‐Based Vocal Fold Implant in Swine. The Laryngoscope. 2026. doi:10.1002/lary.70144

BibTeX
@article{Delavary2026,
  author = {Delavary, Desiree and Nicolas, Larissa and Sajed, Dipti and Alhiyari, Yazeed and Long, Jennifer},
  title = {Safety and Toxicity Evaluation of Stem Cell‐Based Vocal Fold Implant in Swine},
  journal = {The Laryngoscope},
  year = {2026},
  doi = {10.1002/lary.70144}
}
Kostenlos starten →